Skip to main content
MyCapitol LogoMyCapitol

S 4918 · 117th Congress

Increasing Prescription Drug Competition Act

<p><b>Increasing Prescription Drug Competition Act</b></p> <p>This bill provides that certifications in generic drug applications of certain patents involved in Risk Evaluation and Mitigation Strategy (REMS) programs have no effect upon the drug's approval. (The Food and Drug Administration sometimes requires a REM…

Sponsor
Hassan, Margaret Wood (D-NH)
Introduced
2022-09-22
Policy area
Health
Latest action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Digging through Congress... 🔍